Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Our latest developments
24 resultaten, getoond 1 t/m 5
Sex hormones determine the risk of liver damage in children with overweight
Research by Maastricht UMC+ and TNO shows that oestradiol protects against liver damage, while androgens such as testosterone are associated with an increased risk, in both girls and boys.


14C-Pulse-Chase Technology
Obesity


Diabetic kidney disease


MASH and liver fibrosis



